Cross Country Healthcare Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Cross Country Healthcare şirketinin toplam hissedar öz sermayesi $424.7M ve toplam borcu $0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $597.4M ve $172.7M dir. Cross Country Healthcare 'in FAVÖK'ü $13.2M faiz karşılama oranı 19.9 dur. Şirketin $64.0M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

Borç/özkaynak oranı

US$0

Borç

Faiz karşılama oranı	19.9x
Nakit	US$64.02m
Eşitlik	US$424.69m
Toplam yükümlülükler	US$172.73m
Toplam varlıklar	US$597.42m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: XXY 'nin kısa vadeli varlıkları ( $336.6M ) kısa vadeli yükümlülüklerini ( $120.7M ) aşıyor.

Uzun Vadeli Yükümlülükler: XXY şirketinin kısa vadeli varlıkları ( $336.6M ) uzun vadeli yükümlülüklerini ( $52.1M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: XXY borçsuzdur.

Borcun Azaltılması: XXY şirketinin 5 yıl önce borç/öz sermaye oranı 43.1% iken borcu yok.

Borç Kapsamı: XXY un borcu yoktur, dolayısıyla işletme nakit akışı tarafından karşılanmasına gerek yoktur.

Faiz Kapsamı: XXY şirketinin borcu bulunmadığından faiz ödemelerinin karşılanması söz konusu değildir.

Cross Country Healthcare Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Third quarter 2024 earnings released: EPS: US$0.077 (vs US$0.37 in 3Q 2023)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Fourth Quarter of 2024

Cross Country Healthcare, Inc. to Report Q3, 2024 Results on Nov 06, 2024

Insider recently sold €216k worth of stock

Second quarter 2024 earnings released: US$0.47 loss per share (vs US$0.60 profit in 2Q 2023)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Third Quarter of 2024

Investor sentiment improves as stock rises 15%

Investor sentiment improves as stock rises 16%

Cross Country Healthcare, Inc. to Report Q2, 2024 Results on Jul 31, 2024

Chief Information Officer recently sold €126k worth of stock

First quarter 2024 earnings released: EPS: US$0.079 (vs US$0.82 in 1Q 2023)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Second Quarter of 2024

Cross Country Healthcare, Inc. Releases Latest Research Findings in the Fourth Annual Installment of the Future of Nursing Survey

Cross Country Healthcare, Inc. to Report Q1, 2024 Results on May 01, 2024

Cross Country Healthcare, Inc., Annual General Meeting, May 14, 2024

Insider recently sold €97k worth of stock

New minor risk - Share price stability

Cross Country Healthcare, Inc. Announces Daniel J. White Departs as Chief Commercial Officer, Effective March 31, 2024

Full year 2023 earnings released: EPS: US$2.07 (vs US$5.09 in FY 2022)

Investor sentiment deteriorates as stock falls 16%

Now 23% undervalued after recent price drop

Cross Country Healthcare, Inc. to Report Q4, 2023 Results on Feb 21, 2024

Senior VP & Chief Accounting Officer recently sold €135k worth of stock

Investor sentiment deteriorates as stock falls 22%

Insider recently sold €122k worth of stock

Third quarter 2023 earnings released: EPS: US$0.37 (vs US$0.94 in 3Q 2022)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Fourth Quarter of 2023

Cross Country Healthcare, Inc. to Report Q3, 2023 Results on Nov 01, 2023

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: US$0.60 (vs US$1.41 in 2Q 2022)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Third Quarter of 2023 and Updates Earnings Guidance for the Year 2023

Cross Country Healthcare, Inc. to Report Q2, 2023 Results on Aug 02, 2023

Cross Country Launches New Xperience App, Creating Comprehensive and Intuitive Job Searching Experience for Healthcare Professionals

First quarter 2023 earnings released: EPS: US$0.82 (vs US$1.67 in 1Q 2022)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Second Quarter of 2023

Full year 2022 earnings released: EPS: US$5.09 (vs US$3.60 in FY 2021)

Investor sentiment improves as stock rises 15%

Cross Country Healthcare, Inc. to Report Q4, 2022 Results on Feb 22, 2023

Cross Country Healthcare, Inc. Appoints Eric Christianson as Its SVP, Intellify Solutions

Cross Country Healthcare, Inc. Appoints Dwayne L. Allen as Board of Directors

Cross Country Healthcare, Inc. (NasdaqGS:CCRN) acquired Hireup Leadership Inc.

Investor sentiment deteriorated over the past week

Cross Country Healthcare, Inc. Announces Venkat Bhamidipati as Member of Board of Directors

Cross Country Healthcare, Inc. Promotes James V. Redd III to Senior Vice President and Chief Accounting Officer

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: EPS: US$0.94 (vs US$0.63 in 3Q 2021)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

Cross Country Healthcare, Inc. to Report Q3, 2022 Results on Nov 02, 2022

Cross Country Healthcare, Inc. (NasdaqGS:CCRN) acquired Substantially all of the assets of Mint Medical Physician Staffing, LP & Lotus Medical Staffing LLC from Mint Medical Physician Staffing, LP and Lotus Medical Staffing.

Cross Country Healthcare, Inc. Terminates Employment of Buffy S. White as Group President, Workforce solutions

Investor sentiment improved over the past week

Cross Country Healthcare, Inc. Revising Financial Guidance for the Third Quarter of 2022

Cross Country Healthcare, Inc. (NasdaqGS:CCRN) has entered into a definitive agreement to acquire Substantially all of the assets of Mint Medical Physician Staffing, LP & Lotus Medical Staffing LLC from Mint Medical Physician Staffing, LP and Lotus Medical Staffing.

Cross Country Healthcare Launches the New Crosscountry.Com

President recently bought €101k worth of stock

Investor sentiment improved over the past week

Cross Country Healthcare, Inc. (NasdaqGS:CCRN) announces an Equity Buyback for $100 million worth of its shares.

Second quarter 2022 earnings released: EPS: US$1.41 (vs US$0.32 in 2Q 2021)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Third Quarter of 2022

Cross Country Healthcare, Inc. Appoints Craig Hoven as Senior Vice President and Managing Consultant of Cejka Search

Investor sentiment improved over the past week

Cross Country Healthcare, Inc. to Report Q2, 2022 Results on Aug 03, 2022

Cross Country Healthcare, Inc.(NasdaqGS:CCRN) dropped from Russell 2000 Value-Defensive Index

First quarter 2022 earnings released: EPS: US$1.67 (vs US$0.54 in 1Q 2021)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Second Quarter of 2022

Cross Country Healthcare, Inc. to Report Q1, 2022 Results on May 04, 2022

Cross Country Healthcare Appoints Daniel J. White to New Chief Commercial Officer

Cross Country Healthcare, Inc., Annual General Meeting, May 17, 2022

Chief Administrative Officer recently sold €333k worth of stock

Cross Country Healthcare, Inc. Provides Earnings Guidance for the First Quarter of 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Cross Country Healthcare Promotes Colin McDonald to Chief Human Resources Officer

Insufficient new directors

Cross Country Healthcare, Inc. to Report Q4, 2021 Results on Feb 23, 2022

Investor sentiment deteriorated over the past week